Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries

The U.S. Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV

Open True Mainstream to compare left, right, and center coverage

1,600+ newsrooms tracked, in English, around the clock. Real newsrooms only — no NGOs, no press releases. Left/Right tags come from reader feedback. No algorithmic feed.